RSENOL 001 Addendum

Read full text Summarise with VIRAT
Authors: Christopher Love
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

RSENOL-001 Addendum Paragraph: ScienceDaily reported March 25, 2026 a major discovery revealing that metformin works not just peripherally but through a previously hidden brain pathway — Rap1 protein suppression in the ventromedial hypothalamus activating specific neurons to lower blood sugar through a central mechanism the peripheral-only model missed for 60 years. RSENOL-001 sovereign longevity stack was built on central-first metabolic theory — that longevity interventions operating at the brain and central nervous system level produce broader and more durable effects than peripheral-only approaches. Combined with BIO-004 v2 NAD+ brain pathway confirmation — two independent central longevity mechanisms confirmed by separate March 2026 publications — the sovereign longevity stack's brain-first architecture is externally validated simultaneously. The peripheral-only cage refused by 60 years of accumulated evidence finally surfacing. Full mechanism restricted. Refusal does not need 60 years to find the right pathway. 🔒 ⟡

Fields of Study & Subjects

Genetics Aging and Longevity in Model Organisms Metabolism Diabetes and Cancer Sirtuins and Resveratrol in Medicine

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 March 2026
Language
EN